Metagenomics Market Report 2025

The metagenomics market size has grown rapidly in recent years. It will grow from $2.01 billion in 2024 to $2.32 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to microbiome research advancements, disease association studies, environmental monitoring needs, agricultural and food applications, biotechnology and industrial processes.

The metagenomics market size is expected to see rapid growth in the next few years. It will grow to $4 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to precision medicine integration, microbial ecology understanding, one health initiatives, bioprospecting and drug discovery, diagnostic and therapeutic innovations. Major trends in the forecast period include technological advancements in sequencing, integration of ai and machine learning, single-cell metagenomics, metagenomic data standardization, consumer wellness and personalized nutrition.

The growing incidence of infectious diseases is a major factor contributing to the expansion of the metagenomics market. Infectious diseases, often referred to as transmissible diseases, are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites, which can be spread from person to person or through various transmission methods. Metagenomics plays a vital role in studying infectious diseases by analyzing the genetic material of microbial communities. This approach allows for a thorough examination of microbial communities linked to infectious agents, offering insights into their composition, genetic diversity, and potential interactions. For example, a report released by the UK Health Security Agency in February 2024 indicated that tuberculosis (TB) cases in England rose by 10.7% in 2023, with 4,850 cases recorded compared to 4,380 in 2022. Consequently, the rising prevalence of infectious diseases is propelling the growth of the metagenomics market.

The expanding agriculture sector is expected to drive the growth of the metagenomics market in the future. The agriculture sector, commonly known as the agricultural industry or farming sector, includes a wide range of activities related to crop cultivation, livestock rearing, and the production of food, fiber, and other agricultural products. Metagenomics enhances precision agriculture by providing insights into microbial communities, enabling farmers to make informed decisions regarding resource management, irrigation, and pest control. For example, a report from the Plant Based Foods Association in January 2023 indicated that plant-based food sales grew by 6.6% in 2022, an increase from 5.9% in 2021, alongside a 10% rise in average retail prices. Thus, the growth of the agriculture sector is fueling the expansion of the metagenomics market.

A prominent trend in the metagenomics market is the adoption of technological advancements. Major companies in the market are actively embracing new genomics technologies to enhance their observational capabilities and maintain their market position. For instance, CD Genomics, a genomics services company based in the US, introduced the Long-Read Metagenomic Sequencing service in May 2023. This cutting-edge technology empowers researchers and scientists to gain a deeper and more accurate understanding of microbial communities. With features such as enhanced resolution, species identification, functional annotation, and comparative analysis, this advanced method is expected to revolutionize metagenomics research by providing unprecedented insights into microbial communities.

Leading companies in the metagenomics market are also focusing on developing innovative products, such as production-scale sequencers, to cater to larger customer bases, increase sales, and boost revenue. A production-scale sequencer is designed for high-throughput DNA sequencing tasks on a large scale. In September 2022, Illumina, Inc., a US-based biotechnology company, launched the NovaSeq X Series (NovaSeq X and NovaSeq X Plus). These sequencers enable quicker, more potent, and environmentally sustainable sequencing. The NovaSeq X Plus, in particular, has the capacity to generate over 20,000 whole genomes annually, showcasing a throughput 2.5 times greater than its predecessors. The efficiency increase accelerates genomic discovery, enhances clinical insights, and contributes to a deeper understanding of diseases. Additionally, the NovaSeq X exhibits a strong commitment to environmental sustainability by significantly reducing packaging waste and weight, along with a 50% reduction in plastic usage compared to its predecessor, the NovaSeq 6000.

In June 2022, Illumina Inc. acquired IDbyDNA, a US-based biotechnology company specializing in metagenomic technology for infectious disease testing and pathogen surveillance, for an undisclosed amount. This acquisition is aimed at accelerating Illumina Inc.'s growth in the metagenomics market and expanding its range of solutions for customers.

Major companies operating in the metagenomics market include Illumina Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies Limited, BGI Group, Eurofins Scientific SE, Arc Bio LLC, Computomics GmbH, Enterome Bioscience, TAKARA BIO INC., Danaher Corporation, ELITechGroup, Metagenomi, Cosmosid Inc., Pattern Ag, Tiny Health, MATIS OHF, Adapsyn Bioscience, Precidiag Inc., One Codex Inc., MetaBi Inc., Zymo Research Corporation, Bluebee Holding BV, Maverix Biomics Inc., Lucigen Corporation.

North America was the largest region in the global metagenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the metagenomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Metagenomics is a scientific research field that explores genetic material (DNA or RNA) directly extracted from environmental samples or complex microbial communities. Rather than isolating and studying individual organisms, metagenomics focuses on analyzing the collective genomic information present in a given sample.

The primary types of products associated with metagenomics include instruments, kits and reagents, and software and services. Instruments are tools and equipment used for sample collection, DNA and RNA extraction, and various workflows such as sequencing, pre-sequencing, and data analysis. Metagenomic applications span diverse fields, including environmental studies, clinical diagnostics, drug discovery, biotechnology, food and nutrition. These products are utilized by a range of end-users, including pharmaceutical industries, research laboratories, biotechnology companies, pathology laboratories, as well as academic and research institutes.

The metagenomics market research report is one of a series of new reports that provides metagenomics market statistics, including metagenomics industry global market size, regional shares, competitors with a metagenomics market share, detailed metagenomics market segments, market trends and opportunities, and any further data you may need to thrive in the metagenomics industry. This metagenomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The metagenomics market consists of revenues earned by entities by providing metagenomic services such as metatranscriptome sequencing, microbial genome sequencing, functional analysis, comparative metagenomics, and metatranscriptomics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.